Agoracom Blog

HPQ’s Electric Propulsion LOI Opens A North American Drone Supply Chain Opportunity

Posted by Alavaro Coronel at 8:05 AM on Friday, June 19th, 2026

When a company moves from testing technology in isolation to evaluating how it could fit inside a broader industrial ecosystem with real customer activity, the commercialization conversation changes.

HPQ Silicon signed a Letter of Intent on June 16, 2026 with LN Innov’ and HPQ technology partner Novacium SAS at Eurosatory 2026, described in the interview as the world’s largest defence and security exhibition. The LOI will evaluate a Canadian-based electric propulsion platform combining Novacium battery technologies, to be marketed under the HPQ ENDURA+ brand, with LN Innov’s electric propulsion systems for North American drone, robotics and defence markets.

This is still an evaluation framework, but it is supported by real industrial signals. LN Innov’ has had more than 20 customers test its electric propulsion systems, with more than a dozen subsequently placing commercial orders. The company is also working toward manufacturing capacity of up to 20,000 drone motors per month in France by the end of Q3 2026.

For HPQ, the strategic importance is its 36.8 percent equity interest in Novacium and its exclusive North American commercialization rights to Novacium technologies. The next 190 days will focus on whether the parties can define the industrialization, manufacturing, supply chain, certification and business structure needed to adapt elements of the European model for North American markets.

WHAT YOU NEED TO KNOW

Commercial Signals: More than 20 customers have tested LN Innov’ electric propulsion systems, and more than a dozen have placed commercial orders.

Manufacturing Scale: LN Innov’ is working toward capacity of up to 20,000 drone motors per month in France by the end of Q3 2026.

Battery Integration: Novacium battery technologies are being evaluated by industrial and defence sector participants for potential integration into future drone and autonomous system platforms.

North American Rights: HPQ holds a 36.8 percent equity interest in Novacium and exclusive North American commercialization rights to its technologies.

Evaluation Window: The LOI provides a 190 day framework to assess industrialization, manufacturing, supply chain requirements, certification pathways, target applications, business structure and potential commercialization strategies.

STRATEGIC IMPLICATIONS

As drone adoption expands across commercial, industrial and defence applications, electric propulsion is becoming a strategic part of the supply chain. Batteries, motors and propulsion systems directly influence range, efficiency, reliability and platform performance.

HPQ’s opportunity is to evaluate whether a model already being deployed in Europe can be adapted for North American markets. LN Innov’ brings electric propulsion expertise and customer activity. Novacium brings advanced silicon enhanced battery technologies. HPQ brings North American commercialization rights and potential exposure through its equity position in Novacium.

The key point is that this is not a standalone battery story. The LOI is aimed at assessing a more integrated propulsion platform that could combine battery technologies, motors and system level requirements for drone, robotics and autonomous system applications.

During the interview, Bernard Tourillon emphasized that HPQ is not changing its core business plan or becoming a drone company. Rather, the company is looking to commercialize its silicon based battery materials and HPQ ENDURA+ batteries through applications where performance and supply chain resilience matter.

INVESTOR TAKEAWAY

HPQ’s LOI with LN Innov’ and Novacium gives the company a potential pathway into North American drone and electric propulsion markets through an integrated platform strategy. LN Innov’ brings demonstrated customer testing, commercial orders and a manufacturing scale up plan in France, while Novacium’s battery technologies are being evaluated for future drone and autonomous system applications.

For HPQ, the attraction is potential direct exposure through its 36.8 percent equity interest in Novacium and exclusive North American commercialization rights. The next 190 days will focus on whether the parties can define an industrial, manufacturing, certification and commercialization structure for North America.

The LOI remains non-binding, does not grant exclusivity, and includes no financial commitments, payment obligations or minimum purchase requirements. Any future collaboration remains subject to further evaluation and definitive agreements. But the setup is clear: HPQ now has a defined evaluation window, a European propulsion company with commercial order activity, and exclusive North American rights to Novacium technologies in a market increasingly focused on secure domestic supply chains.

 

Tags: , ,

Comments are closed.